Costs and Limitations

  • Developer organization name: Cyfluent
  • Certification Date: 13 August 2019
  • Product name: Cyfluent
  • Product version: Cyfluent 3.2
  • Certification number: 15.04.04.2975.Cyfl.03.00.1.190813
  • This Complete EHR is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
  • Additional software used:
    –Change Healthcare. Providers must be signed up with Change Healthcare to access e-prescribing. The cost for basic e-prescribing is included in the monthly provider fee for the Cyfluent Professional Suite. There is an additional fee for electronic prescribing of controlled substances.
    –Secure Exchange Solutions. Providers must also be signed up with a HISP for direct messaging which is also included in the monthly provider fee for the Cyfluent Professional Suite.
    -Persivia. Providers must be signed up with Persivia for monitoring, managing, and reporting of clinical quality measures. There is an additional monthly fee for this service.
  • There is a Monthly Provider fee for Cyfluent Professional Suite which includes all costs needed for fully certified EHR.
  • Certification criterion or criteria to which the product has been certified:
    · 170.315 (a)(1): Computerized Provider Order Entry (CPOE) – Medications
    · 170.315 (a)(2): CPOE – Laboratory
    · 170.315 (a)(3): CPOE – Diagnostic Imaging
    · 170.315 (a)(4): Drug-Drug, Drug-Allergy Interaction Checks for CPOE
    · 170.315 (a)(5): Demographics
    · 170.315 (a)(9): Clinical Decision Support
    · 170.315 (a)(12): Family Health History
    · 170.315 (a)(14): Implantable Device List
    · 170.315 (a)(15): Social, Psychological, and Behavioral Determinants Data
    · 170.315 (b)(1): Transitions of Care
    · 170.315 (b)(2): Clinical Information Reconciliation and Incorporation
    · 170.315 (b)(3): Electronic Prescribing (Cures Update)
    · 170.315 (b)(6): Data Export
    · 170.315 (b)(7): Data Segmentation for Privacy – Send
    · 170.315 (b)(8): Data Segmentation for Privacy – Receive
    · 170.315 (b)(9): Care Plan
    · 170.315 (c)(1): Clinical Quality Measures – Record and Export
    · 170.315 (c)(2): Clinical Quality Measures – Import and Calculate
    · 170.315 (c)(3): Clinical Quality Measures – Report
    · 170.315 (d)(1): Authentication, Access Control, Authorization
    · 170.315 (c)(4): Clinical Quality Measures – Filter
    · 170.315 (d)(1): Authentication, Access Control, Authorization
    · 170.315 (d)(2): Auditable Events and Tamper-Resistance
    · 170.315 (d)(3): Audit Report(s)
    · 170.315 (d)(4): Amendments
    · 170.315 (d)(5): Automatic Access Time-out
    · 170.315 (d)(6): Emergency Access
    · 170.315 (d)(7): End-User Device Encryption
    · 170.315 (d)(8): Integrity
    · 170.315 (d)(9): Trusted Connection
    · 170.315 (d)(10): Auditing Actions on Health Information
    · 170.315 (e)(3): Patient Health Information Capture
    · 170.315 (f)(1): Transmission to Immunization Registries
    · 170.315 (f)(4): Transmission to Cancer Registries
    · 170.315 (f)(5): Transmission to Public Health Agencies – Electronic Case Reporting
    · 170.315 (g)(3): Safety-Enhanced Design
    · 170.315 (g)(4): Quality Management
    · 170.315 (g)(5): Accessibility-Centered Design
    · 170.315 (g)(6): Consolidated CDA Creation
    · 170.315 (g)(7): Application Access – Patient Selection
    · 170.315 (g)(8): Application Access – Data Category Request
    · 170.315 (g)(9): Application Access – All Data Request
    · 170.315 (h)(2): Direct Project, Edge Protocol, and XDR/XDM
    · CMS2: Preventive Care and Screening: Screening for Depression and Follow-Up Plan
    · CMS50: Closing the Referral Loop: Receipt of Specialist Report
    · CMS122: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
    · CMS124: Cervical Cancer Screening
    · CMS125: Breast Cancer Screening
    · CMS127: Pneumococcal Vaccination Status for Older Adults
    · CMS130: Colorectal Cancer Screening
    · CMS131: Diabetes: Eye Exam
    · CMS134: Diabetes: Medical Attention for Nephropathy
    · CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
    · CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
    · CMS139: Falls: Screening for Future Fall Risk
    · CMS147: Preventive Care and Screening: Influenza Immunization
    · CMS149: Dementia: Cognitive Assessment
    · CMS156: Use of High-Risk Medications in the Elderly
    · CMS159: Depression Remission at Twelve Months
    · CMS160: Depression Utilization of the PHQ-9 Tool
    · CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antiplatelet
    · CMS165: Controlling High Blood Pressure
    · CMS166: Use of Imaging Studies for Low Back Pain
    · CMS347: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease